Understanding Carboxyhemoglobin Testing

Carbon monoxide (CO) is a colorless, odorless gas produced by incomplete combustion of fuels such as gas, oil, wood, and coal. When inhaled, CO binds to hemoglobin in red blood cells with an affinity roughly 200–250 times greater than oxygen, forming carboxyhemoglobin (COHb). This prevents oxygen from being transported to tissues, leading to cellular hypoxia. A CO test, typically performed on arterial or venous blood, measures the percentage of hemoglobin saturated with CO. This value is critical for diagnosing poisoning, guiding treatment, and preventing long-term neurological damage.

The COHb level alone does not always tell the full story. Clinical presentation, exposure duration, and individual health status are equally important. However, the numeric result provides an objective starting point for decision-making in emergency departments, occupational health settings, and even home monitoring with modern pulse CO-oximeters.

Normal COHb Levels and Baseline Variations

In healthy non-smokers living in areas without significant air pollution, COHb levels are typically below 2%. Endogenous production from heme catabolism contributes a small baseline of about 0.4–0.7%. Urban dwellers may have slightly higher levels, up to 1–2%, due to vehicle exhaust. Smokers, however, can exhibit markedly elevated baselines: a pack-a-day smoker often has COHb levels between 5% and 10%, and heavy smokers may exceed 10% even without acute poisoning.

Other factors that influence baseline COHb include:

  • Occupational exposure: Firefighters, mechanics, tollbooth workers, and welders may have chronic low-level CO exposure.
  • Altitude: Higher altitudes reduce ambient oxygen, which can slightly increase COHb binding affinity.
  • Exercise: During physical exertion, increased ventilation and cardiac output can accelerate CO uptake if exposure occurs.
  • Medical conditions: Hemolytic anemias cause increased endogenous CO production from red blood cell breakdown.

Understanding an individual’s baseline is critical when interpreting an acute CO test result. A non-smoker with a COHb of 8% is likely experiencing significant poisoning, whereas the same level in a heavy smoker may represent only a moderate excess above their baseline.

Interpreting CO Test Results by Percentage Range

The numerical COHb level is traditionally used as a guide for severity, but correlation with symptoms is imperfect. The following ranges offer a general framework for interpretation, keeping in mind that symptoms can vary widely based on duration of exposure, age, and health status.

Less than 2% (Non-smokers)

This is the normal physiological range. No action is needed unless the patient has concomitant symptoms suggestive of another condition. For smokers, levels up to 10% may be normal, but any acute rise warrants investigation.

2–5% (Non-smokers: Slight elevation)

In non-smokers, this range indicates mild environmental or occupational exposure. Typically asymptomatic, but headache or mild fatigue may occur. The primary action is removal from the source of CO and ensuring adequate ventilation. No medical treatment is usually required, but follow-up should be arranged if symptoms develop.

5–10% (Moderate exposure)

Non-smokers in this range often experience headache, dizziness, and nausea. Smokers with a high baseline may be in this range chronically and feel relatively normal, but any acute increase above their baseline should be treated as significant. Medical evaluation is recommended, with administration of high-flow oxygen via a non-rebreather mask (15 L/min) until symptoms resolve and COHb falls below 5%.

10–15% (Significant exposure)

At this level, most patients will have clear symptoms: confusion, visual disturbances, chest pain in those with coronary artery disease, and impaired coordination. Immediate medical attention is necessary. High-flow oxygen should be started en route to the hospital. Obtain an electrocardiogram and assess for metabolic acidosis. Consider hyperbaric oxygen therapy (HBOT) if neurological symptoms are present or if the patient is pregnant.

15–25% (Severe poisoning)

This range indicates life-threatening exposure. Patients may be disoriented, unconscious, or seizing. Immediate high-flow oxygen, IV access, and full cardiac monitoring are required. Emergency services should be activated without delay. HBOT is strongly recommended for patients with loss of consciousness, neurological deficits, severe metabolic acidosis, or COHb >25%. Even with treatment, the risk of delayed neurological sequelae (DNS) is high.

Above 25% (Critical)

Levels above 25% are often fatal without aggressive intervention. In addition to immediate oxygen therapy, consider intubation for airway protection, mechanical ventilation with 100% oxygen, and urgent HBOT. Survivors frequently require rehabilitation for cognitive deficits. Any COHb >30% in a child under 5 years or above 20% in a pregnant woman demands the highest level of urgency.

When to Act: Clinical Decision-Making

While COHb percentages provide a useful snapshot, treatment decisions must integrate symptoms, exposure history, and patient-specific factors. Acting based solely on numbers can lead to undertreatment (e.g., a symptomatic patient with COHb of 8% from chronic exposure) or overtreatment (e.g., an asymptomatic smoker with 10% baseline).

Immediate Action Required

  • COHb ≥15% in any patient (consider lower thresholds for pregnant women, infants, and elderly).
  • Any level of COHb with loss of consciousness, seizures, altered mental status, or neurological deficits.
  • Signs of myocardial ischemia (chest pain, ECG changes) or arrhythmia in the presence of CO exposure.
  • Metabolic acidosis (pH <7.2) associated with CO poisoning.
  • Pregnant patient with COHb >10% or any level with fetal distress.

In these cases, call emergency medical services immediately, remove the patient from the CO source, and administer high-flow oxygen. Do not wait for confirmatory tests if the clinical picture is clear; treatment should begin simultaneously with testing.

Action Within 1–2 Hours

  • COHb between 10% and 15% with symptoms such as headache, nausea, or dizziness but no neurological signs.
  • COHb between 5% and 10% in a patient with known cardiovascular disease or respiratory compromise.
  • Any COHb level in a child under 2 years with even mild symptoms.

These patients should be transported to an emergency department for evaluation, oxygen therapy, and observation. Discharge is appropriate only if symptoms resolve and COHb drops below 5% with several hours of supplemental oxygen and a safe home environment is ensured.

Observation and Outpatient Management

  • COHb <10% in an asymptomatic non-smoker, or <15% in an asymptomatic smoker, with a known, limited exposure and no comorbidities.
  • Patients who have already been removed from the source and have no symptoms.

Such individuals may be monitored at home after a period of oxygen therapy, provided they have a working CO detector and a reliable contact for follow-up. However, due to the risk of delayed neurological effects, any development of symptoms within 24 hours warrants reevaluation.

Special Populations at Higher Risk

Children

Children have higher metabolic rates and oxygen consumption, making them more vulnerable to CO toxicity. Their faster respiratory rates lead to increased CO uptake. COHb levels above 10% in children are considered serious, and above 20% is critical. Fetal hemoglobin binds CO more tightly, so pregnant women and their unborn children require lower thresholds for intervention.

Elderly Patients

Older adults often have diminished cardiovascular reserve and may experience myocardial ischemia or dysrhythmia at COHb levels as low as 5%. Pre-existing cognitive impairment can mask subtle neurological signs. Aggressive oxygen therapy and a low threshold for hospital admission are advised.

Patients with Chronic Lung or Heart Disease

Individuals with COPD, congestive heart failure, or coronary artery disease are at increased risk of hypoxic injury. A COHb level of 5–10% can provoke decompensation. These patients should be evaluated in a hospital setting even if asymptomatic.

Treatment Modalities: Oxygen Therapy and Beyond

The cornerstone of CO poisoning treatment is the administration of high-concentration oxygen to accelerate CO elimination. The half-life of COHb in room air is approximately 4–5 hours; with 100% oxygen via non-rebreather it drops to about 60–90 minutes, and with hyperbaric oxygen at 2.5–3 atmospheres it can be as short as 20–30 minutes. Key interventions include:

  • High-flow oxygen: 15 L/min via non-rebreather mask immediately. Continue until COHb is <5% and symptoms resolve.
  • Hyperbaric oxygen therapy (HBOT): Reduces the risk of DNS. Indications: loss of consciousness, neurological deficits, COHb >25%, pregnancy with COHb >15%, or severe metabolic acidosis. HBOT should be administered within 6 hours of exposure for maximum benefit.
  • Supportive care: Cardiac monitoring, IV fluids for hypotension, treatment of acidosis with bicarbonate (controversial), and management of seizures or arrhythmias.

Long-term follow-up is essential for patients with moderate-to-severe poisoning, as DNS—characterized by cognitive decline, memory loss, and movement disorders—can appear weeks after initial recovery.

Prevention: The Best Intervention

Interpreting CO test results is only part of the picture. Preventing exposure altogether is far more effective. Key preventive measures include:

  • Installing CO detectors on every level of the home and near sleeping areas. Test alarms monthly and replace batteries at least annually.
  • Servicing fuel-burning appliances (furnaces, water heaters, stoves, dryers) annually by a qualified technician.
  • Never running generators or grills indoors or in attached garages, even with doors open.
  • Proper ventilation when using space heaters, kerosene lamps, or charcoal briquettes.
  • Avoiding idling vehicles in enclosed spaces, including garages attached to living areas.

For high-risk occupations, employers should provide personal CO monitors, ensure proper ventilation, and conduct regular air quality testing. Workers should be educated about early symptoms and emergency procedures.

Conclusion: Integrated Approach to CO Poisoning

CO test results are a vital diagnostic tool, but they should never be interpreted in isolation. A holistic assessment that includes symptom severity, duration of exposure, patient age and comorbidities, and the context of the poisoning event will guide appropriate action. When in doubt, err on the side of caution: administer oxygen, monitor for neurological deterioration, and consult a toxicologist or hyperbaric specialist for severe cases.

As with many medical emergencies, early recognition and prompt treatment dramatically improve outcomes. By understanding the nuances of COHb interpretation and knowing when to escalate care, healthcare providers and even informed laypersons can save lives and prevent the devastating consequences of carbon monoxide poisoning.

For more information, consult the CDC carbon monoxide poisoning page or the World Health Organization’s fact sheet.